$321.80
Price
$22.7B
Market Cap
43.1
P/E Ratio
33.7
Forward P/E
$7.47
EPS (TTM)
0.27%
Dividend Yield
$521M
Cash
$321M
Total Debt
71M
Shares Out
$206.10
$330.88
52-Week Range
Institutional Ownership of WEST PHARMACEUTICAL SVSC INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Gates Foundation Trust|Michael Larson
|
444.5K | $111M | $232.76 | +20.04% | |
|
Hillman Capital Management|Mark Hillman
|
8.9K | $2M | $246.20 | +0.64% |
Trading Activity for WEST PHARMACEUTICAL SVSC INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | -13.3% | 8.9K | $2M | $273.16 | |
| 2025-Q3 | |||||
| BUY | NEW | 10.3K | $3M | $246.20 | |
| 2025-Q1 | |||||
| BUY | NEW | 444.5K | $100M | $232.76 | |
| 2018-Q4 | |||||
| SELL | EXIT | — | — | $107.70 | |
| 2018-Q3 | |||||
| SELL | -1.1% | 22.9K | $3M | $115.96 | |
| 2018-Q2 | |||||
| SELL | -5.4% | 23.2K | $2M | $90.95 | |
Insider Trading for WEST PHARMACEUTICAL SVSC INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.